TusHoldings plans to acquire 100% equity of Guangdong Xantong

Guangdong Xiantong Pharmaceutical Co., Ltd. is mainly a pharmaceutical production enterprise, pre-processing and extraction workshops of traditional Chinese medicine (oral preparations), tablets, hard capsules and granules, etc. The company has a total of 18 products, of which 2 are the main products of the company (Xiaotangling Tablets and Yixinshu Tablets), which are mainly used for diabetes, cardiovascular and cerebrovascular diseases, and strive to include Xiaotangling Tablets in the national medical insurance products. Recently acquired by TusHoldings, the post-investment valuation was not disclosed, accounting for 100%.

This article is reprinted from: https://www.itjuzi.com/merger/8847
This site is for inclusion only, and the copyright belongs to the original author.

Leave a Comment